Explore FHI 360

Country

Eswatini

In Eswatini (formerly Swaziland), FHI 360 focuses on mitigating the impacts of HIV among women and children by improving and expanding opportunities for community development, strengthening child protection, promoting gender equality and increasing...

Tools

Meeting Targets and Maintaining Epidemic Control (EpiC): Success Stories

These success stories highlight the progress of EpiC country programs.

Published research

Size estimation of key populations in the HIV epidemic in eSwatini using incomplete and misaligned capture-recapture data

External Article

Study findings raise women’s hope

Tools

Meeting Targets and Maintaining Epidemic Control (EpiC): Country Resources

These resources offer knowledge and tools from EpiC country programs that can be utilized to strengthen HIV and COVID-19 programming efforts worldwide.

Tools

Linkages across the Continuum of HIV Services for Key Populations Affected by HIV (LINKAGES): Success Stories

The Linkages across the Continuum of HIV Services for Key Populations Affected by HIV (LINKAGES) project conducts a range of HIV prevention activities to reduce HIV transmission among key populations (sex workers, men who have sex with men,...

News

FHI 360 commends updated guidance on contraception for women at high risk of HIV

FHI 360 welcomes the World Health Organization’s updated guidance on contraceptive use by women at high risk of acquiring HIV infection and applauds the thoughtful, thorough review process that led to these new recommendations.

Published research

HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: A randomised, multicentre, open-label trial

The ECHO trial, a randomized clinical trial, was developed to address a long-standing question about the possible association of hormonal contraceptives with increased HIV acquisition risk. This article presents the data from research sites in Eswatini, Kenya, South Africa and Zambia. The results indicate there were no substantial differences in HIV incidence associated with use of three licensed contraceptive methods and supports continued and expanded access to these methods.

News

FHI 360 responds to release of landmark ECHO Study results

FHI 360 responds to the release of the landmark ECHO Study results.

News

ECHO Study of hormonal contraception and HIV begins

FHI 360 and partners embark on a landmark study designed to fill a critical gap in the scientific evidence on the relationship between HIV acquisition and hormonal contraceptives.

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Eswatini

Meeting Targets and Maintaining Epidemic Control (EpiC): Success Stories

Size estimation of key populations in the HIV epidemic in eSwatini using incomplete and misaligned capture-recapture data

Study findings raise women’s hope

Meeting Targets and Maintaining Epidemic Control (EpiC): Country Resources

Linkages across the Continuum of HIV Services for Key Populations Affected by HIV (LINKAGES): Success Stories

FHI 360 commends updated guidance on contraception for women at high risk of HIV

HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: A randomised, multicentre, open-label trial

FHI 360 responds to release of landmark ECHO Study results

ECHO Study of hormonal contraception and HIV begins

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Search within these results

20 Results Found

HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: A randomised, multicentre, open-label trial